Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001789617-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
21,215
Total Value
$302,516.29
P&L
+inf% (+$571,480.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF COMMERCIAL OFFICER | Common Stock | โ | Apr 13, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 145,823 | Direct | โ | View Details | |
CHIEF COMMERCIAL OFFICER | Common Stock | โ | Apr 14, 2026 | Sale | 7,215 | $41.93 | $302,516.29 | 138,608 | Direct | โ | View Details |